SAN FRANCISCO, Bugcrowd has secured $102 million in strategic growth financing to scale its AI-powered crowdsourced security platform offerings globally. Read More
BOSTON, MA, Alys Pharmaceuticals, an immuno-dermatology focused company, launches today with an R&D pipeline enabled by multiple platform technologies and a $100 million financing by Medicxi. Read More
